Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE)
Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE)
Active, not recruiting · NCT03767348 · Registry updated 2026-02-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE) | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Non-Melanoma Skin Neoplasms, Skin and Connective Tissue Diseases, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, cutaneous melanoma, lung disorder, lung neoplasm, melanocytic neoplasm, melanoma, mismatch repair cancer syndrome 1, neoplasm, neuroendocrine neoplasm, non-small cell lung carcinoma, primitive neuroectodermal tumor, respiratory system disorder, respiratory tract neoplasm, skin disorder, skin neoplasm | Active, not recruiting | Phase 2 | 2026-02-13 | NCT03767348 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bristol-Myers Squibb | 422 |
| Replimune, Inc. | 14 |
51 results · Page 1 of 3
Research sites
Swipe the table sideways for more columns.